Physician profile
Mitchell Bartley
NPI 1548559461
$657.25
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $12.08 · 2022: $65.11.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $112.65 | 2019 | |
| Pfizer INC. | $83.19 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.33 | 2019 | |
| Organogenesis INC. | $65.11 | 2022 | |
| Amgen INC. | $62.45 | 2019 | |
| Lilly USA, LLC | $56.03 | 2019 | |
| Novo Nordisk INC | $43.11 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.13 | 2019 | |
| Sanofi Pasteur INC. | $31.99 | 2019 | |
| Allergan, INC. | $15.07 | 2019 | |
| Ironshore Pharmaceuticals INC. | $14.93 | 2019 | |
| Mylan Specialty L.P. | $13.18 | 2019 | |
| Glaxosmithkline, LLC. | $11.46 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Bartley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.